John Steytler

775 total citations
8 papers, 109 citations indexed

About

John Steytler is a scholar working on Infectious Diseases, Virology and Microbiology. According to data from OpenAlex, John Steytler has authored 8 papers receiving a total of 109 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Virology and 3 papers in Microbiology. Recurrent topics in John Steytler's work include HIV/AIDS Research and Interventions (7 papers), HIV Research and Treatment (5 papers) and HIV/AIDS drug development and treatment (3 papers). John Steytler is often cited by papers focused on HIV/AIDS Research and Interventions (7 papers), HIV Research and Treatment (5 papers) and HIV/AIDS drug development and treatment (3 papers). John Steytler collaborates with scholars based in United States, South Africa and United Kingdom. John Steytler's co-authors include Bríd Devlin, Hugo Tempelman, Neliëtte van Niekerk, Sylvia Kusemererwa, Allison Carter, Philip Kotze, Katherine Gill, Zonke Mabude, Linda‐Gail Bekker and Elna van der Ryst and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and AIDS Research and Human Retroviruses.

In The Last Decade

John Steytler

8 papers receiving 109 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Steytler United States	4	84	39	37	36	12	8	109
Lillian Okui United States	6	81 1.0×	44 1.1×	59 1.6×	35 1.0×	22 1.8×	8	116
Ishana Harkoo South Africa	6	88 1.0×	39 1.0×	49 1.3×	27 0.8×	10 0.8×	14	107
Aram Limtrakul Thailand	7	87 1.0×	31 0.8×	47 1.3×	46 1.3×	7 0.6×	10	125
Brenda Gati Mirembe Uganda	5	103 1.2×	31 0.8×	59 1.6×	42 1.2×	15 1.3×	12	124
Elizabeth Hellström United States	6	153 1.8×	47 1.2×	83 2.2×	24 0.7×	16 1.3×	6	173
Rachel Scheckter United States	7	93 1.1×	50 1.3×	69 1.9×	18 0.5×	17 1.4×	17	123
Lameck Chinula United States	7	69 0.8×	42 1.1×	30 0.8×	15 0.4×	10 0.8×	26	119
Fredrick Owino Kenya	5	136 1.6×	94 2.4×	62 1.7×	20 0.6×	23 1.9×	10	171
Anne-Sophie Sauvage Belgium	7	104 1.2×	9 0.2×	61 1.6×	40 1.1×	21 1.8×	10	135
Rosana Fonseca Brazil	6	108 1.3×	66 1.7×	47 1.3×	18 0.5×	3 0.3×	10	133

Countries citing papers authored by John Steytler

Since Specialization

Citations

This map shows the geographic impact of John Steytler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Steytler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Steytler more than expected).

Fields of papers citing papers by John Steytler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Steytler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Steytler. The network helps show where John Steytler may publish in the future.

Co-authorship network of co-authors of John Steytler

This figure shows the co-authorship network connecting the top 25 collaborators of John Steytler. A scholar is included among the top collaborators of John Steytler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Steytler. John Steytler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Achilles, Sharon L., Clifton W. Kelly, Craig Hoesley, et al.. (2024). Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings. PLoS ONE. 19(6). e0304552–e0304552. 2 indexed citations

Steytler, John, Charles Craig, Elna van der Ryst, et al.. (2022). Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction. Clinical Infectious Diseases. 76(6). 996–1002. 3 indexed citations

Steytler, John, Elna van der Ryst, Charles Craig, et al.. (2022). Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials—The Ring Study and DREAM. Clinical Infectious Diseases. 76(3). 389–397. 1 indexed citations

Liu, Albert, Holly Gundacker, Blažej Neradilek, et al.. (2021). Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States. Journal of the International AIDS Society. 24(6). e25747–e25747. 17 indexed citations

McGowan, Ian, Craig W. Hendrix, Peter A. Anton, et al.. (2021). A Randomized, Open-Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study). AIDS Research and Human Retroviruses. 38(4). 269–278. 7 indexed citations

Nel, Annaléne, Neliëtte van Niekerk, Ben Van Baelen, et al.. (2021). Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. The Lancet HIV. 8(2). e77–e86. 71 indexed citations

Nel, Annaléne, Neliëtte van Niekerk, Allison Carter, et al.. (2014). Baseline Characteristics of HIV-negative Women Enrolled into the Ring Study - A Clinical Trial of the Dapivirine Vaginal Ring for HIV-1 Prevention. AIDS Research and Human Retroviruses. 30(S1). A289–A289. 1 indexed citations

Odendaal, H J, Susan Brink, & John Steytler. (1978). Clinical and haematological problems associated with severe abruptio placentae.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 54(12). 476–80. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact